BCRX Annual Current Liabilities
$149.99 M
+$44.47 M+42.15%
31 December 2023
Summary:
As of January 22, 2025, BCRX annual total current liabilities is $149.99 million, with the most recent change of +$44.47 million (+42.15%) on December 31, 2023. During the last 3 years, it has risen by +$44.33 million (+41.96%). BCRX annual current liabilities is now at all-time high.BCRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Quarterly Current Liabilities
$153.57 M
+$24.50 M+18.98%
30 September 2024
Summary:
As of January 22, 2025, BCRX quarterly total current liabilities is $153.57 million, with the most recent change of +$24.50 million (+18.98%) on September 30, 2024. Over the past year, it has increased by +$3.58 million (+2.39%). BCRX quarterly current liabilities is now at all-time high.BCRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.1% | +2.4% |
| 3 y3 years | +42.0% | +14.9% |
| 5 y5 years | +115.9% | +86.9% |
BCRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.6% | at high | +89.5% |
| 5 y | 5-year | at high | +62.4% | at high | +89.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
BioCryst Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $153.57 M(+19.0%) |
| June 2024 | - | $129.06 M(+7.6%) |
| Mar 2024 | - | $119.92 M(-20.0%) |
| Dec 2023 | $149.99 M(+42.1%) | $149.99 M(+65.3%) |
| Sept 2023 | - | $90.76 M(-2.9%) |
| June 2023 | - | $93.50 M(+9.8%) |
| Mar 2023 | - | $85.16 M(-19.3%) |
| Dec 2022 | $105.51 M(+1.7%) | $105.51 M(+29.2%) |
| Sept 2022 | - | $81.64 M(-14.4%) |
| June 2022 | - | $95.39 M(+17.7%) |
| Mar 2022 | - | $81.02 M(-21.9%) |
| Dec 2021 | $103.72 M(-1.8%) | $103.72 M(-22.4%) |
| Sept 2021 | - | $133.61 M(+15.6%) |
| June 2021 | - | $115.60 M(+14.2%) |
| Mar 2021 | - | $101.20 M(-4.2%) |
| Dec 2020 | $105.65 M(+14.4%) | $105.65 M(-5.5%) |
| Sept 2020 | - | $111.78 M(+8.9%) |
| June 2020 | - | $102.65 M(+10.7%) |
| Mar 2020 | - | $92.70 M(+0.4%) |
| Dec 2019 | $92.33 M(+32.9%) | $92.33 M(+12.4%) |
| Sept 2019 | - | $82.17 M(+14.2%) |
| June 2019 | - | $71.95 M(+8.5%) |
| Mar 2019 | - | $66.33 M(-4.5%) |
| Dec 2018 | $69.48 M(-7.2%) | $69.48 M(+8.0%) |
| Sept 2018 | - | $64.36 M(-13.2%) |
| June 2018 | - | $74.17 M(-1.6%) |
| Mar 2018 | - | $75.34 M(+0.7%) |
| Dec 2017 | $74.84 M(+37.7%) | $74.84 M(+8.1%) |
| Sept 2017 | - | $69.24 M(+17.5%) |
| June 2017 | - | $58.94 M(+0.6%) |
| Mar 2017 | - | $58.56 M(+7.7%) |
| Dec 2016 | $54.36 M(-12.7%) | $54.36 M(+5.5%) |
| Sept 2016 | - | $51.52 M(-8.3%) |
| June 2016 | - | $56.19 M(-10.9%) |
| Mar 2016 | - | $63.07 M(+1.3%) |
| Dec 2015 | $62.26 M(+8.7%) | $62.26 M(-3.4%) |
| Sept 2015 | - | $64.44 M(+1.1%) |
| June 2015 | - | $63.77 M(+3.1%) |
| Mar 2015 | - | $61.86 M(+8.0%) |
| Dec 2014 | $57.29 M(+275.5%) | $57.29 M(+15.0%) |
| Sept 2014 | - | $49.82 M(+10.9%) |
| June 2014 | - | $44.94 M(+228.3%) |
| Mar 2014 | - | $13.69 M(-10.3%) |
| Dec 2013 | $15.26 M(-11.4%) | $15.26 M(+15.7%) |
| Sept 2013 | - | $13.18 M(+10.2%) |
| June 2013 | - | $11.96 M(+5.6%) |
| Mar 2013 | - | $11.32 M(-34.3%) |
| Dec 2012 | $17.22 M(-34.5%) | $17.22 M(+37.1%) |
| Sept 2012 | - | $12.56 M(-34.2%) |
| June 2012 | - | $19.11 M(+18.2%) |
| Mar 2012 | - | $16.16 M(-38.5%) |
| Dec 2011 | $26.30 M(-6.1%) | $26.30 M(+36.0%) |
| Sept 2011 | - | $19.33 M(-12.0%) |
| June 2011 | - | $21.96 M(+0.9%) |
| Mar 2011 | - | $21.77 M(-22.2%) |
| Dec 2010 | $28.00 M(-24.8%) | $28.00 M(+38.3%) |
| Sept 2010 | - | $20.25 M(+34.1%) |
| June 2010 | - | $15.10 M(-28.4%) |
| Mar 2010 | - | $21.09 M(-43.4%) |
| Dec 2009 | $37.25 M | $37.25 M(+110.1%) |
| Sept 2009 | - | $17.73 M(+31.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $13.46 M(-0.7%) |
| Mar 2009 | - | $13.56 M(-20.7%) |
| Dec 2008 | $17.11 M(-39.2%) | $17.11 M(-2.6%) |
| Sept 2008 | - | $17.56 M(+1.2%) |
| June 2008 | - | $17.35 M(-33.1%) |
| Mar 2008 | - | $25.95 M(-7.7%) |
| Dec 2007 | $28.12 M(+161.9%) | $28.12 M(+13.7%) |
| Sept 2007 | - | $24.73 M(+44.2%) |
| June 2007 | - | $17.16 M(+26.3%) |
| Mar 2007 | - | $13.58 M(+26.5%) |
| Dec 2006 | $10.73 M(-5.7%) | $10.73 M(-16.8%) |
| Sept 2006 | - | $12.90 M(+33.3%) |
| June 2006 | - | $9.68 M(-12.0%) |
| Mar 2006 | - | $11.01 M(-3.3%) |
| Dec 2005 | $11.38 M(+301.6%) | $11.38 M(+230.2%) |
| Sept 2005 | - | $3.45 M(+52.5%) |
| June 2005 | - | $2.26 M(-15.7%) |
| Mar 2005 | - | $2.68 M(-5.3%) |
| Dec 2004 | $2.83 M(+110.2%) | $2.83 M(-13.3%) |
| Sept 2004 | - | $3.27 M(+58.8%) |
| June 2004 | - | $2.06 M(-7.5%) |
| Mar 2004 | - | $2.23 M(+65.0%) |
| Dec 2003 | $1.35 M(+54.6%) | $1.35 M(+19.2%) |
| Sept 2003 | - | $1.13 M(-12.0%) |
| June 2003 | - | $1.28 M(+44.9%) |
| Mar 2003 | - | $887.00 K(+1.7%) |
| Dec 2002 | $872.00 K(-56.0%) | $872.00 K(-6.6%) |
| Sept 2002 | - | $934.00 K(-31.6%) |
| June 2002 | - | $1.36 M(-11.1%) |
| Mar 2002 | - | $1.53 M(-22.6%) |
| Dec 2001 | $1.98 M(-51.9%) | $1.98 M(+147.8%) |
| Sept 2001 | - | $800.00 K(-80.5%) |
| June 2001 | - | $4.10 M(+20.7%) |
| Mar 2001 | - | $3.40 M(-17.6%) |
| Dec 2000 | $4.12 M(+142.5%) | $4.12 M(+342.3%) |
| Sept 2000 | - | $932.00 K(-38.8%) |
| June 2000 | - | $1.52 M(+16.9%) |
| Mar 2000 | - | $1.30 M(-23.3%) |
| Dec 1999 | $1.70 M(+54.5%) | $1.70 M(+41.7%) |
| Sept 1999 | - | $1.20 M(+20.0%) |
| June 1999 | - | $1.00 M(+11.1%) |
| Mar 1999 | - | $900.00 K(-18.2%) |
| Dec 1998 | $1.10 M(+22.2%) | $1.10 M(-26.7%) |
| Sept 1998 | - | $1.50 M(+36.4%) |
| June 1998 | - | $1.10 M(-21.4%) |
| Mar 1998 | - | $1.40 M(+55.6%) |
| Dec 1997 | $900.00 K(-35.7%) | $900.00 K(-25.0%) |
| Sept 1997 | - | $1.20 M(-14.3%) |
| June 1997 | - | $1.40 M(+7.7%) |
| Mar 1997 | - | $1.30 M(-7.1%) |
| Dec 1996 | $1.40 M(+27.3%) | $1.40 M(+16.7%) |
| Sept 1996 | - | $1.20 M(-14.3%) |
| June 1996 | - | $1.40 M(+27.3%) |
| Mar 1996 | - | $1.10 M(0.0%) |
| Dec 1995 | $1.10 M(+37.5%) | $1.10 M(+57.1%) |
| Sept 1995 | - | $700.00 K(-12.5%) |
| June 1995 | - | $800.00 K(+33.3%) |
| Mar 1995 | - | $600.00 K(-25.0%) |
| Dec 1994 | $800.00 K | $800.00 K(+14.3%) |
| Sept 1994 | - | $700.00 K(-46.2%) |
| June 1994 | - | $1.30 M(-7.1%) |
| Mar 1994 | - | $1.40 M |
FAQ
- What is BioCryst Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual current liabilities year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly current liabilities year-on-year change?
What is BioCryst Pharmaceuticals annual total current liabilities?
The current annual current liabilities of BCRX is $149.99 M
What is the all time high annual current liabilities for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total current liabilities is $149.99 M
What is BioCryst Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, BCRX annual total current liabilities has changed by +$44.47 M (+42.15%)
What is BioCryst Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of BCRX is $153.57 M
What is the all time high quarterly current liabilities for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total current liabilities is $153.57 M
What is BioCryst Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, BCRX quarterly total current liabilities has changed by +$3.58 M (+2.39%)